Study summary

In this study several dose levels of ASP3652, given orally for 12 weeks, will be compared with placebo in the treatment of female patients with Bladder Pain Syndrome / Interstitial Cystitis.

Additional Study Details

Phase
2
Product
N/A
Product
ASP3652
Placebo
Type
Interventional
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
287
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A Randomized Study comparing Placebo and ASP3652 in the treatment of women with Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Site: 6301
    Vilnius, Lithuania, 09108
    Completed
    Site: 5302
    Naestved, Denmark, 4700
    Completed
    Site 6202
    Laguna, Tenerife, Spain, 38330
    Completed
    Site 5901
    Porto, Portugal, 4200-319
    Completed
    Site 6002
    Bucharest, Romania, 042122
    Completed
    Site 6203
    Barcelona, Spain, 08024
    Completed
    Site: 5805
    Piaseczno, Poland, 05-500
    Completed
    Site: 6302
    Vilnius, Lithuania, 08661
    Completed
    Site: 5803
    Warsaw, Poland, 02-784
    Completed
    Site: 5402
    Holzminden, Germany, 37603
    Completed
    Site: 5601
    Riga, Latvia, 1002
    Completed
    Site 6101
    Moscow, Russian Federation, 127473
    Completed
    Site: 5603
    Riga, Latvia, 1038
    Completed
    Site 6005
    Iasi, Romania, 700503
    Completed
    Site: 5602
    Liepaja, Latvia, 3401
    Completed
    Site 6006
    Brasov, Romania, 500152
    Completed
    Site: 5802
    Warsaw, Poland, 00-865
    Completed
    Site 5806
    Bydgoszcz, Poland, 85-094
    Completed
    Site: 5203
    Kromeriz, Czech Republic, 767 55
    Completed
    Site 6103
    Moscow, Russian Federation, 105425
    Completed
    Site: 6303
    Vilnius, Lithuania, 10207
    Completed
    Site: 5702
    Winterswijk, Netherlands, 7101 BN
    Completed
    Site: 5409
    Frankfurt am Main, Germany, 60590
    Completed
    Site 6204
    Malaga, Spain, 29009
    Completed
    Site 6108
    Moscow, Russian Federation, 101000
    Withdrawn
    Site 6109
    Moscow, Russian Federation, 123995
    Completed
    Site: 5301
    Herlev, Denmark, 2730
    Completed
    Site: 5303
    Aarhus, Denmark, 8200
    Completed
    Site 5903
    Porto, Portugal, 4099-001
    Completed
    Site: 5801
    Lodz, Poland, 90-447
    Completed
    Site 5902
    Coimbra, Portugal, 3000-075
    Completed
    Site 6004
    Bucharest, Romania, 021392
    Withdrawn
    Site 6107
    Tomsk, Russian Federation, 634063
    Completed
    Site: 5405
    Mainz, Germany, 55131
    Withdrawn
    Site 6104
    Moscow, Russian Federation, 105425
    Completed
    Site 6003
    Bucharest, Romania, 0100-000
    Completed
    Site: 6111
    Moscow, Russian Federation, 115682
    Completed
    Site: 5206
    Olomouc, Czech Republic, 775 20
    Withdrawn
    Site: 5407
    Moenchengladbach, Germany, 41063
    Completed
    Site: 5812
    Poznan, Poland, 61-397
    Completed
    Site: 5406
    Duisburg, Germany, 47179
    Completed
    Site: 5414
    Offenburg, Germany, 77654
    Withdrawn
    Site 6105
    Omsk, Russian Federation, 644013
    Withdrawn
    Site: 5408
    Reutlingen, Germany, 72764
    Completed
    Site: 5202
    Kralove, Czech Republic, 500 05
    Completed
    Site: 5403
    Emmendingen, Germany, 79312
    Completed
    Site: 5811
    Chorzow, Poland, 41-500
    Withdrawn
    Site: 5705
    Gouda, Netherlands, 2803 HH
    Completed
    Site: 5210
    Sternberk, Czech Republic, 785 01
    Completed
    Site: 5209
    Plzen, Czech Republic, 301 00
    Completed
    Site: 5807
    Bialystok, Poland, 15-224
    Withdrawn
    Site 5105
    Brussels, Belgium, 1000
    Withdrawn
    Site: 5104
    Kortrijk, Belgium, 8500
    Completed
    Site: 5703
    Maastricht, Netherlands, 6229 HX
    Completed
    Site: 5704
    Zwijndrecht, Netherlands, 3331 LZ
    Withdrawn
    Site: 5401
    Herne, Germany, 44627
    Completed
    Site 6201
    Barcelona, Spain, 08850
    Completed
    Site: 5103
    Brussels, Belgium, 1070
    Completed
    Site 6007
    Bucharest, Romania, 022328
    Completed
    Site 6001
    Targu Mures, Romania, 540103
    Completed
    Site: 5804
    Warsaw, Poland, 01-432
    Completed
    Site: 5101
    Antwerp, Belgium, 2650
    Withdrawn
    Site: 5207
    Usti nad Labem, Czech Republic, 401 13
    Completed
    Site: 5706
    Amsterdam, Netherlands, 1081HV
    Completed
    Site: 5201
    Uherske Hradiste, Czech Republic, 686 68
    Withdrawn
    Site: 5208
    Jablonec nad Nisou, Czech Republic, 466 60
    Completed
    Site: 5701
    Nijmegen, Netherlands, 6525 GA
    Completed
    Site 6102
    St.-Petersburg, Russian Federation, 197022
    Withdrawn
    Site: 5102
    Gent, Belgium, 9000
    Withdrawn
    Site 6110
    Rostov-on-Don, Russian Federation, 344022
    Completed
    Site 6106
    Moscow, Russian Federation, 117997
    Completed
    Site 5410
    Kirchheim, Germany, 73270
    Completed
    Site: 6304
    Kaunas, Lithuania, 50154
    Completed
    Site: 5404
    Nurtingen, Germany, 72622
    Withdrawn
    Site: 5205
    Praha, Czech Republic, 121 08

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?